Bellevue Group AG Q2 2018 Filing

Filed August 7, 2018

Portfolio Value

$1.2T

Holdings

138

Report Date

Q2 2018

Filing Type

13F-HR

All Holdings (138 positions)

#StockSharesValue% PortfolioType
101
IDXXIDEXX LABS INC
7,000$1.5B0.13%
102
3M4MASIMO CORP
14,800$1.4B0.12%
103
CLLSCELLECTIS S A
50,600$1.4B0.12%
104
OXFORD IMMUNOTEC GLOBAL PLC
110,661$1.4B0.12%
105
ITCIEURINTRA CELLULAR THERAPIES INC
79,900$1.4B0.12%
106
DVAXDYNAVAX TECHNOLOGIES CORP
91,800$1.4B0.12%
107
ARNAEURARENA PHARMACEUTICALS INC
31,417$1.4B0.12%
108
ALKSALKERMES PLC
32,650$1.3B0.11%
109
STIMNEURONETICS INC
50,000$1.3B0.11%
110
AETNA INC NEW
7,100$1.3B0.11%
111
MRTXEURMIRATI THERAPEUTICS INC
25,500$1.3B0.11%
112
8INSYNEOS HEALTH INC
26,656$1.3B0.11%
113
AMRXAMNEAL PHARMACEUTICALS INC
75,000$1.2B0.10%
114
CASTLIGHT HEALTH INC
287,340$1.2B0.10%
115
FOUNDATION MEDICINE INC
8,357$1.1B0.10%
116
TESARO INC
25,250$1.1B0.10%
117
INGNINOGEN INC
6,011$1.1B0.10%
118
COTIVITI HLDGS INC
24,774$1.1B0.09%
119
PFEPFIZER INC
29,200$1.1B0.09%
120
GW PHARMACEUTICALS PLC
7,179$1.0B0.09%
121
ENDO INTL PLC
99,092$934.0M0.08%
122
CAHCARDINAL HEALTH INC
18,000$879.0M0.07%
123
VEEVVEEVA SYS INC
10,296$791.0M0.07%
124
CLVSEURCLOVIS ONCOLOGY INC
17,250$784.0M0.07%
125
QUREUNIQURE NV
20,200$764.0M0.07%
126
MRKMERCK & CO INC
12,500$759.0M0.06%
127
VAREURVARIAN MED SYS INC
6,300$716.0M0.06%
128
ADAPYADAPTIMMUNE THERAPEUTICS PLC
59,935$711.0M0.06%
129
BELLICUM PHARMACEUTICALS INC
90,020$664.0M0.06%
130
HCSGHEALTHCARE SVCS GRP INC
15,000$648.0M0.06%
131
MEDICINES CO
17,050$626.0M0.05%
132
CVSCVS HEALTH CORP
8,000$515.0M0.04%
133
MTLSMATERIALISE NV
39,329$510.0M0.04%
134
NTLAINTELLIA THERAPEUTICS INC
16,734$458.0M0.04%
135
MEDIDATA SOLUTIONS INC
4,649$375.0M0.03%
136
AAC HLDGS INC
39,000$365.0M0.03%
137
VYGRVOYAGER THERAPEUTICS INC
16,922$331.0M0.03%
138
AURIS MED HLDG AG
193,125$151.0M0.01%
PreviousPage 2 of 2